Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 7,415 $ 13,172
Other receivables 136 1,919
Inventory, net 0 20
Prepaid expenses and other current assets 843 1,290
Restricted cash, current portion 1 15
Total current assets 8,395 16,416
Property and equipment, net 1,965 2,411
Goodwill 10,502 14,409
Restricted cash, net of current portion 131 131
Total assets 20,993 33,367
Current liabilities:    
Accounts payable 446 2,882
Deferred revenue 0 88
Accrued expenses and other current liabilities 4,172 13,214
Notes payable, current 0 5,930
Total current liabilities 4,618 22,114
Notes payable, non-current 0 13,486
Royalty obligation 2,000 2,000
Deferred tax liability, net 155 141
Derivative liability 5,550 4,830
Other long-term liabilities 1,366 1,711
Total liabilities 13,689 44,282
Stockholders’ equity (deficit) :    
Common stock—$0.001 par value; 200,000,000 shares authorized at December 31, 2023 and 2022; 801,746 and 39,295 shares issued and outstanding at December 31, 2023 and 2022, respectively [1] 1 0
Additional paid-in capital [1] 342,437 292,909
Accumulated deficit (335,134) (303,824)
Total stockholders’ equity (deficit) 7,304 (10,915)
Total liabilities and stockholders’ equity (deficit) $ 20,993 $ 33,367
[1] Amounts for prior periods presented have been retroactively adjusted to reflect the 1-for-240 reverse stock split effected on December 28, 2023. See Note 1 for details.